Marco Ladetto

University Hospital Schleswig-Holstein — Germany

Medicine · Health Sciences

66h-index15.8kcitations506works3.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(284), Chronic Lymphocytic Leukemia Research(193), Viral-associated cancers and disorders(91), Multiple Myeloma Research and Treatments(62), CAR-T cell therapy research(49)

Publications504 total

Functional characterization of snoRNA-derived RNA (sdRNA) expression in healthy hematopoiesis and acute myeloid leukemia
2026Open Access
The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial
Leukemia·2025Open Access
Mosunetuzumab in combination with zanubrutinib is safe in patients with relapsed/refractory follicular lymphoma: Safety run-in results from the FIL-mozart Phase II study
Blood·2025Open Access
Increased incidence of secondary malignancies after autologous stem cell transplantation in follicular lymphoma patients: Long-term results of the FIL-FLAZ12 Phase III randomized trial
Blood·2025Open Access
Noninvasive genotyping and early disease dynamics demonstrate the efficacy of ibrutinib in combination with immunochemotherapy in patients with mantle cell lymphoma treated in the TRIANGLE trial
Leukemia·2025Open Access
Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib-based regimens: Insights from the TRIANGLE trial within the MULTIPLY project
Blood·2025Open Access
Feasibility and safety of bispecific antibodies outpatient model in triple-refractory multiple myeloma patients in two Italian centers
Blood·2025
Phase 2 trial of zilovertamab vedotin in combination with cyclophosphamide, doxorubicin, and prednisone plus rituximab in diffuse large B-cell lymphoma: Updated analysis of waveline-007
Blood·2025Open Access
Final efficacy results of the real-life ambispective urban study on frontline obinutuzumab-based immunochemotherapy for advanced follicular lymphoma
Blood·2025Open Access
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020
Haematologica·2025Open Access
EHA–EU MCL network guidelines for diagnosis and treatment of mantle cell lymphoma
HemaSphere·2025· 2 citedOpen Access
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 study
The Lancet Haematology·2025· 2 cited
A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection
Hematological Oncology·2025Open Access
Circulating Plasma Cells Evaluation Before and After CAR T-cell Therapy as a Dynamic Factor for Response Assessment
Clinical Lymphoma Myeloma & Leukemia·2025
IBCL-767: Clonal Hematopoiesis in Follicular Lymphoma: Analysis of the Phase 3 FIL FOLL12 Trial
Clinical Lymphoma Myeloma & Leukemia·2025
POSTER: IBCL-767 Clonal Hematopoiesis in Follicular Lymphoma: Analysis of the Phase 3 FIL FOLL12 Trial
Clinical Lymphoma Myeloma & Leukemia·2025
The MCL elderly III trial protocol: an international, randomized, open-label phase II trial to investigate the combinations of venetoclax, ibrutinib and rituximab or bendamustine, ibrutinib and rituximab in patients with treatment naive mantle cell lymphoma not eligible for dose-intensive treatment
BMC Cancer·2025Open Access
Outcomes of CAR T-cell therapy in high-grade B-cell lymphomas compared to DLBCL: a weighted comparison analysis
Blood Advances·2025· 1 citedOpen Access
Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Annals of Oncology·2025· 15 cited
Author response for "A SWOT‐Consensus for CAR‐T in Follicular Lymphoma: Fine Tuning of Patient Journey and Selection"
2025
page 1 of 26Next →

Frequent Co-authors

Mario Boccadoro(14), Umberto Vitolo(13), Paolo Corradini(13), Emanuele Zucca(9), Luca Arcaini(8), Alessandro Pileri(8), Corrado Tarella(8), Giorgio Inghirami(8), Gianluca Gaïdano(8), Simone Ferrero(7), Claudia Voena(7), Jan Walewski(6), Pier Luigi Zinzani(6), Roberto Passera(6), Davide Rossi(6), Monica Astolfi(6), María Gomes da Silva(5), M. Dreyling(5), Elı́as Campo(5), Daniela Drandi(5)